Palvella Therapeutics, Inc.
PVLANasdaqCIK 1583648HealthcareFiscal year ends Dec 31
All transactions: 5
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-21 | Goin KathleenChief Operating Officer, Officer | Sale | 607 | $126.1949 | $76.6k | Form 4 |
| 2026-10-21 | Goin KathleenChief Operating Officer, Officer | Sale | 1,663 | $125.1645 | $208.1k | Form 4 |
| 2026-10-21 | Goin KathleenChief Operating Officer, Officer | Sale | 2,043 | $123.6214 | $252.6k | Form 4 |
| 2026-10-21 | Goin KathleenChief Operating Officer, Officer | Option exercise | 2,148 | $9.08 | $19.5k | Form 4 |
| 2026-10-21 | Goin KathleenChief Operating Officer, Officer | Option exercise | 2,165 | $7.14 | $15.5k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 28, 2026, 07:31 ET. Listed shows no prices and gives no investment advice.